FDA Inspection 1260937 — Laboratoires Druide inc.

Laboratoires Druide inc. — FEI 3008226137

The FDA completed an inspection of Laboratoires Druide inc. on February 14, 2025 in Pointe-Claire. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 8 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
February 14, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pointe-Claire (Canada)

Citations

IDCFRDescription
111121 CFR 211.25(a)Training , Education , Experience overall
117721 CFR 211.63Equipment Design, Size and Location
121521 CFR 211.67(b)Written procedures not established/followed
126121 CFR 211.68(a)Written calibration / inspection records not kept
136121 CFR 211.100(a)Absence of Written Procedures
183321 CFR 211.84(d)(1)Identity Testing of Each Component
194221 CFR 211.180(e)Records reviewed annually
360221 CFR 211.160(a)Deviations from laboratory control requirements